Hepatocellular Carcinoma With Small Bowel Metastasis and Intussusception: A Case Report and Literature Review.
증례보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: gastrointestinal symptoms or unexplained elevated tumor markers
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] Small intestine metastasis from HCC, although rare, should be considered in patients with gastrointestinal symptoms or unexplained elevated tumor markers. Surgical resection is the most effective treatment approach, with minimally invasive and endoscopic techniques available for select cases.
[BACKGROUND] Hepatocellular carcinoma (HCC) is a common primary liver malignancy.
APA
Hsu MK, Chen PD, Wu YM (2025). Hepatocellular Carcinoma With Small Bowel Metastasis and Intussusception: A Case Report and Literature Review.. Cancer reports (Hoboken, N.J.), 8(12), e70364. https://doi.org/10.1002/cnr2.70364
MLA
Hsu MK, et al.. "Hepatocellular Carcinoma With Small Bowel Metastasis and Intussusception: A Case Report and Literature Review.." Cancer reports (Hoboken, N.J.), vol. 8, no. 12, 2025, pp. e70364.
PMID
41318218 ↗
Abstract 한글 요약
[BACKGROUND] Hepatocellular carcinoma (HCC) is a common primary liver malignancy. Despite advancements in treatment, HCC often has a poor prognosis because of frequent recurrence and metastasis. Hematogenous metastasis to the gastrointestinal tract is uncommon, and metastasis to the small intestine is particularly rare.
[CASE] We report a case of a 72-year-old man with a history of hepatitis C virus and alcohol-related HCC. In 2017, he was initially managed with atypical hepatectomy of segments 5 and 6. He later developed bone and lung metastases, controlled by sequential systemic therapies. In early 2024, after undergoing a craniotomy for hemorrhagic occipital brain metastasis, he presented with diffuse abdominal pain, fullness, and vomiting. Imaging revealed distal ileal intussusception. A segmental small bowel resection was performed, and a fungating ileal tumor was identified as the lead point. Histology confirmed metastatic HCC (i.e., Hepar-1 positive). The postoperative course was uneventful, but within 3 months, new metastatic lesions appeared in the stomach and left breast; the latter was treated with a partial mastectomy.
[CONCLUSION] Small intestine metastasis from HCC, although rare, should be considered in patients with gastrointestinal symptoms or unexplained elevated tumor markers. Surgical resection is the most effective treatment approach, with minimally invasive and endoscopic techniques available for select cases.
[CASE] We report a case of a 72-year-old man with a history of hepatitis C virus and alcohol-related HCC. In 2017, he was initially managed with atypical hepatectomy of segments 5 and 6. He later developed bone and lung metastases, controlled by sequential systemic therapies. In early 2024, after undergoing a craniotomy for hemorrhagic occipital brain metastasis, he presented with diffuse abdominal pain, fullness, and vomiting. Imaging revealed distal ileal intussusception. A segmental small bowel resection was performed, and a fungating ileal tumor was identified as the lead point. Histology confirmed metastatic HCC (i.e., Hepar-1 positive). The postoperative course was uneventful, but within 3 months, new metastatic lesions appeared in the stomach and left breast; the latter was treated with a partial mastectomy.
[CONCLUSION] Small intestine metastasis from HCC, although rare, should be considered in patients with gastrointestinal symptoms or unexplained elevated tumor markers. Surgical resection is the most effective treatment approach, with minimally invasive and endoscopic techniques available for select cases.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.